BioMarin Pharmaceutical Inc
(NAS:BMRN)
$
60.02
-0.56 (-0.92%)
Market Cap: 11.60 Bil
Enterprise Value: 10.82 Bil
PE Ratio: 43.81
PB Ratio: 1.87
GF Score: 79/100 
BioMarin Pharmaceutical Inc at Leerink Global Healthcare Conference Transcript
Mar 09, 2026 / 12:00PM GMT
Release Date Price:
$60.88
(-0.39%)
Joseph Schwartz
Leerink Partners LLC - Analyst
(audio in progress) -- BioMarin, it's my pleasure to host. I'm Joe Schwartz and I'm pleased to be joined by Brian Mueller, Chief Financial Officer, and Cristin Hubbard, Chief Commercial Officer.
Thanks for joining us.
Brian Mueller
BioMarin Pharmaceutical Inc - Chief Financial Officer, Executive Vice President and Principal Financial Officer
Thanks for having us, Joe. Good morning. Excited.
Cristin Hubbard
BioMarin Pharmaceutical Inc - Executive Vice President, Chief Commercial Officer
(multiple speakers) -- to be here.
Joseph Schwartz;Brian Mueller
Leerink Partners LLC - Analyst;BioMarin Pharmaceutical Inc - Chief Financial Officer, Executive Vice President
So before we get into individual products, Brian, can you frame what's driving BioMarin's next phase of growth, particularly the mix of near-term commercial execution, upcoming pipeline milestones, and portfolio expansion?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers